Hexyon/Hexacima 6-in-1 pediatric vaccine approved in Europe
22 April 2013 | By Sanofi Pasteur
Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine...
List view / Grid view
22 April 2013 | By Sanofi Pasteur
Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine...
22 February 2013 | By Sanofi
The EMA recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine...
11 September 2012 | By Sanofi Pasteur
“The complexity of dengue virus infection has hampered vaccine research for decades..."
25 July 2012 | By Sanofi Pasteur
Early data analysis confirms excellent safety profile...
22 June 2012 | By Sanofi Pasteur
Sanofi Pasteur, announced that HexaximTM received a positive scientific opinion...
26 April 2012 | By Linda Starr-Spires, Director, Nucleic Acid Methods Platform, Global Clinical Immunology Department, Sanofi Pasteur
The process of building robust PCR/qPCR assays is a matter of perseverance and consistency. A few questions that should be answered prior to starting development will help make the process more efficient and effective: Does the assay need to simply detect the presence of the target (qualitative), or must it…
18 January 2012 | By Sanofi Pasteur
Brazil has chosen to introduce injectable polio vaccine in its national immunization program...
21 September 2011 | By Sanofi Pasteur
The pre-clinical vaccine was developed by researchers at the University of California...
25 July 2011 | By College Hill Ltd
LEUKOCARE AG, announced the signing of a cooperation agreement with Sanofi Pasteur...
23 June 2011 | By Sanofi Pasteur
Sanofi Pasteur, announced that the WHO has granted prequalification to its Typhim Vi® polysaccharide typhoid vaccine...
10 May 2011 | By Sanofi Pasteur
The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone Intradermal...
22 April 2011 | By Sanofi Pasteur
Sanofi Pasteur announces that the FDA has granted licensure to expand the indication for its meningococcal conjugate vaccine...
21 April 2011 | By Merck
Combination vaccine designed to help protect against 6 diseases: diphtheria, tetanus, whooping cough, polio, Haemophilus influenzae type b, and hepatitis B...
18 October 2010 | By Emma Naylor, NG Online News
Pharmaceutical heads met last week as a result of a drugs recall after an ingrediant mix up in breast cancer pill Anastrozole.
2 July 2010 | By NG Online News
The pharmaceutical industry has faced well documented challenges over the last 12 months, such as the Pfizer...